Zento Yamada - Publications

Efficacy of romosozumab as sequential therapy for bisphosphonates in glucocorticoid-induced osteoporosis.

Journal: JBMR plus

Published: March 08, 2026

Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: January 27, 2026

Anti-SRP antibody-positive polymyositis complicated by neuromyelitis optica spectrum disorder: a case report and literature review.

Journal: Modern rheumatology case reports

Published: September 29, 2025

Effect of Tirzepatide Treatment on Hepatic Biomarkers in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes Mellitus.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: March 25, 2025

Comparison of Efficacy of Romosozumab With Denosumab and Risedronate in Patients Newly Initiating Glucocorticoid Therapy.

Journal: The Journal of clinical endocrinology and metabolism

Published: August 01, 2024

Associations of gut microbiota with disease development, disease activity, and therapeutic effects in patients with systemic lupus erythematosus.

Journal: Scientific reports

Published: July 31, 2024

Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational study.

Journal: Arthritis research & therapy

Published: December 02, 2023

A case of systemic lupus erythematosus in a patient with Noonan syndrome with recurrent severe hypoglycaemia.

Journal: Modern rheumatology case reports

Published: November 07, 2023

Corrigendum: Senescence of alveolar epithelial cells impacts initiation and chronic phases of murine fibrosing interstitial lung disease.

Journal: Frontiers in immunology

Published: April 06, 2023

Senescence of alveolar epithelial cells impacts initiation and chronic phases of murine fibrosing interstitial lung disease.

Journal: Frontiers in immunology

Published: May 03, 2022

Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study.

Journal: Rheumatology and therapy

Published: May 24, 2021

Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 06, 2021